Frontiers
US$ 29.33
glp-1 obesity drug news today september 2025 New Daily Weight Loss Pill Aims to Take on Ozempic New Guidelines on GLP-1 Drugs
Description
+6.5pp absolute difference First open-label head-to-head between single and dual receptor agonists
Tissue Barriers
Glucagon-Like Peptide-1 Receptor Action in the Vasculature
Topical application is not prohibited
PMID: 36870274
